Though the surge in Sierra Leone has received much of the attention, cases are also rising in two other countries in West Africa: Ghana and Liberia.
The test the US Centers for Disease Control and Prevention uses to identify clade I mpox cases is 'most likely not reliable' for detection of the substrain identified in the study, the authors say.
Another mpox study today showed that dose-sparing vaccine administration of the Jynneos vaccine appeared to have worked.
Receive the latest infectious disease information.
According to a new non-peer reviewed study out of Israel, the Jynneos vaccine is 79% effective against monkeypox infection.
The study was based on patients eligible for monkeypox vaccine seen in the Clalit Health Services system between Jul 31 and Sep 12, 2022. Of 1,970 subjects eligible for the study, 873 (44%) were vaccinated with Jynneos and completed at least 25 days of follow-up.
Steady drops in new cases continue in North America and Europe, resulting in a 22% overall decline.
The COVID-19 pandemic dramatically worsened disparities in all-cause death rates for American Indian and Alaska Native (AIAN), Native Hawaiian, other Pacific Islander (NHOPI), and Black Americans and eroded mortality advantages for Asian and Hispanic groups, finds a study published yesterday in PNAS.
Boston public schools (BPS) yesterday announced the first monkeypox case in an "adult member of the BPS community," according to a letter sent to parents. The school district said the person was isolating at home, and the district was working to identify exposed individuals.
One of the Florida infant's 4 caretakers reported high-risk activities before the baby contracted monkeypox.
"As we implement the interventions that we have, simultaneously, we still pursue some unanswered questions."
CDC Director Walensky says patients and clinicians likely did not recognize this new infection early on.
Two men in their 30s developed encephalomyelitis, or inflammation of the brain and spinal cord.
Bavarian Nordic researchers show that 1- and 2-dose subcutaneous Jynneos vaccinations induce durable neutralizing antibody responses.
MSM should be advised that certain sexual practices and lifestyles put them at very high risk.
